Literature DB >> 30225971

Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis.

N Mumoli1, D Mastroiacovo1, M Giorgi-Pierfranceschi1, R Pesavento1, M Mochi2, M Cei1, F Pomero1, A Mazzone1, J Vitale3, W Ageno3, F Dentali3.   

Abstract

Essentials Ultrasound elastography uses tissue deformation to assess the relative quantification of its elasticity. Compression and duplex ultrasonography may be unable to correctly determine the thrombus age. Ultrasound elastography may be useful to distinguish between acute and chronic deep vein thrombosis. The exact determination of the thrombus age could have both therapeutic and prognostic implications.
BACKGROUND: Background Ultrasound elastography (UE) imaging is a novel sonographic technique that is commonly employed for relative quantification of tissue elasticity. Its applicability to venous thromboembolic events has not yet been fully established; in particular, it is unclear whether this technique may be useful in determining the age of deep vein thrombosis (DVT). Thus, the aim of this study was to assess the role of UE in distinguishing acute from chronic DVT. Methods Consecutive patients with a first unprovoked acute and chronic (3 months old) DVT of the lower limbs were analyzed. Patients with recurrent DVT or with a suspected recurrence were excluded. The mean elasticity index (EI) values of acute and chronic popliteal and femoral vein thrombosis were compared. The accuracy of the EI in distinguishing acute from chronic DVT was also assessed by measuring the sensitivity, specificity, positive and negative predictive values, and likelihood ratios. Results One-hundred and forty-nine patients (mean age 63.9 years, standard deviation 13.6; 73 males) with acute and chronic DVT were included. The mean EI of acute femoral DVT was higher than that of chronic femoral DVT (5.09 versus 2.46), and the mean EI of acute popliteal DVT was higher than that of chronic popliteal DVT (4.96 versus 2.48). An EI value of > 4 resulted in a sensitivity of 98.9% (95% confidence interval [CI] 93.3-99.9), a specificity of 99.1% (95% CI 94.8-99.9), a positive predictive value of 91.1% (95% CI 77.9-97.1), a negative predictive value of 98.6% (95% CI 91.3-99.9), a positive likelihood ratio of 13.23 (95% CI 93-653) and a negative likelihood ratio of 0.001 (95% CI 0.008-0.05) for acute DVT. Conclusions UE appears to be a promising technique for distinguishing between acute and chronic DVT. Larger prospective studies are warranted to confirm our preliminary findings.
© 2018 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  accuracy; deep vein thrombosis; diagnosis; elastography; ultrasound

Mesh:

Year:  2018        PMID: 30225971     DOI: 10.1111/jth.14297

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  3 in total

1.  Standardized Fabrication Method of Human-Derived Emboli with Histologic and Mechanical Quantification for Stroke Research.

Authors:  Yang Liu; Adithya S Reddy; Joshua Cockrum; Miranda C Ajulufoh; Yihao Zheng; Albert J Shih; Aditya S Pandey; Luis E Savastano
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-08-07       Impact factor: 2.677

2.  Impact of routine preoperative sonographic screening with early intervention for deep venous thrombosis in lower extremities on preventing postoperative venous thromboembolism in patients with gastric cancer scheduled for minimally invasive surgery.

Authors:  Kazumitsu Suzuki; Susumu Shibasaki; Masaya Nakauchi; Kenichi Nakamura; Shingo Akimoto; Tsuyoshi Tanaka; Kenji Kikuchi; Kazuki Inaba; Ichiro Uyama; Koichi Suda
Journal:  Langenbecks Arch Surg       Date:  2021-09-01       Impact factor: 2.895

3.  Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi.

Authors:  Samuel A Hendley; Alexey Dimov; Aarushi Bhargava; Erin Snoddy; Daniel Mansour; Rana O Afifi; Geoffrey D Wool; Yuanyuan Zha; Steffen Sammet; Zheng Feng Lu; Osman Ahmed; Jonathan D Paul; Kenneth B Bader
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.